Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2003
11/20/2003WO2003042357A3 Enzymes
11/20/2003WO2003040344A3 Transcription factor stress-related polypeptides and methods of use in plants
11/20/2003WO2003038048A3 Ex-vivo rescue of transplantable hematopoietic stem cells following myeloablative injury
11/20/2003WO2003031567A3 Precursor conversion screening methods
11/20/2003WO2003027306A3 Bgl3 beta-glucosidase and nucleic acids encoding the same
11/20/2003WO2003025134A3 mcFP ENCODING NUCLEIC ACIDS, POLYPEPTIDES, ANTIBODIES AND METHODS OF USE THEREOF
11/20/2003WO2003023018A3 A method for isolating, culturing and differentiating intestinal stem cells for therapeutic use
11/20/2003WO2003023006A3 Hemocyanin nucleic acids and polypeptides and related vectors, fusion proteins, conjugates, cells and methods of use
11/20/2003WO2003023004A3 Antisense modulation of fibroblast growth factor receptor 3 expression
11/20/2003WO2003020931A3 Sirna knockout assay method and constructs
11/20/2003WO2003018767A3 Trans-differentiation and re-differentiation of somatic cells and production of cells for cell therapies
11/20/2003WO2003016506A3 Secreted proteins
11/20/2003WO2003012062A3 Animal model with disrupted fgf14 gene
11/20/2003WO2003012054A3 Methods and compositions relating to improved lentiviral vector production systems
11/20/2003WO2003006647A9 Allene oxide synthase and divinyl ether synthase from the cyp74-enzyme family isolated out of physcomitrella patens, the nucleotide sequences that code these synthases, and method for producing pathogen-resistant plants
11/20/2003WO2003006616A3 Pseudotyped adeno-associated viruses and uses thereof
11/20/2003WO2003004627B1 Novel human hepatoma lines, methods for obtaining same and uses thereof
11/20/2003WO2003004613A3 Novel pgc-1 isoforms and uses therefor
11/20/2003WO2003000864A3 Nucleic acid-associated proteins
11/20/2003WO2003000021A3 Pancam nucleic acids and polypeptides
11/20/2003WO2002101045A3 Vanilloid receptor-related nucleic acids and polypeptides
11/20/2003WO2002095011A3 Inactivation of genes of the mep pathway
11/20/2003WO2002090530A3 Kinases and phosphatases
11/20/2003WO2002083736A3 G-protein coupled receptor molecules and uses thereof
11/20/2003WO2002079249A3 New polynucleotides and polypeptides of the ifn$g(a)-21 gene
11/20/2003WO2002077246A3 Site-targeted transformation using amplification vectors
11/20/2003WO2002070703A8 Cell visual characteristic-modifying sequences
11/20/2003WO2002062395A3 A method and system for introducing a gene into a human stem cell
11/20/2003WO2002060935A3 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences
11/20/2003WO2002057408A8 Chitinases, derived from carnivorous plants polynucleotide sequences encoding thereof, and methods of isolating and using same
11/20/2003WO2002055547A3 Sfrp and peptide motifs that interact with sfrp and methods of their use
11/20/2003WO2002052015A3 Self-replicating rna molecule from hepatitis c virus
11/20/2003WO2002038744A3 Proteases
11/20/2003WO2002033050A8 Methods and compositions for promoting the maturation of monocytes
11/20/2003WO2001061006A9 Two pore potassium channels, nucleotide sequences encoding them, and methods of using same
11/20/2003US20030217390 Plant brassinolide responsive genes and use thereof
11/20/2003US20030217385 Comprises insect-toxic peptide/fusion proteins for use in generating disease resistant plants; biological pest control; disease resistant plants
11/20/2003US20030217379 Defective tyrosine phosphatase animal model for diagnosing and treating diabetes and eating disorders
11/20/2003US20030217373 Transgenic animals bearing human Ig-lambda light chain genes
11/20/2003US20030216812 Vascularization enhanced graft constructs
11/20/2003US20030216811 Vascularization enhanced graft constructs
11/20/2003US20030216562 Genetic engineered polypeptides; binding to antibodies; recovering culture product
11/20/2003US20030216561 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/20/2003US20030216560 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/20/2003US20030216559 Medical diagnosis using polypeptide; amplification, determination, calibration; monitoring immunotherapy
11/20/2003US20030216558 Novel compositions and methods for cancer
11/20/2003US20030216549 Comprises modified chemokine for use as antiinflammatory, viricidal or antiallergenic agent
11/20/2003US20030216548 Sp110, a polypeptide component of the nuclear body
11/20/2003US20030216339 Gene sequences associated with neural plasticity and methods related thereto
11/20/2003US20030216322 Containing the motif E(L/V/S)RGDS
11/20/2003US20030216317 Protein having cell-recognizing activity and/or cytocidal activity
11/20/2003US20030216305 Identification and characterization of a polypeptide having homology to the sarcoma-amplified protein SAS
11/20/2003US20030216288 Methods and compositions for treating aids and HIV-related disorders using 1414, 1481, 1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784, or 2045 molecules
11/20/2003US20030215948 Comprises adenoviral particle with reduced binding responses to heparin sulfate proteoglycans (HSP) for use as tools in gene therapy and genetic engineering
11/20/2003US20030215946 Biodegradable, porous structures useful for growing living tissue, and methods of manufacture
11/20/2003US20030215945 Methods and compositions for organ decellularization
11/20/2003US20030215942 Preparing stem cell libraries for therapeutic use in event of exposure to nuclear radiation
11/20/2003US20030215941 Assay device that analyzes the absorption, metabolism, permeability and/or toxicity of a candidate compound
11/20/2003US20030215921 Vascular endothelial growth factor-2
11/20/2003US20030215919 Phosphodiesterase 8A
11/20/2003US20030215918 Comprises nucleotide sequences coding tyrosine kinase receptor binding protein (EFL-1) for treating and diagnosing cell proliferative disorders
11/20/2003US20030215912 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptides; cancer diagnosis
11/20/2003US20030215911 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/20/2003US20030215910 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/20/2003US20030215904 Comprises membrane protein for treatment and diagnosis of cell proliferative disorders; antitumor/anticarcinogenic agents
11/20/2003US20030215898 Methods for using 22045, a human cyclic nucleotide phosphodiesterase
11/20/2003US20030215893 Nucleic acids, proteins, and antibodies
11/20/2003US20030215889 Membrane preparation comprising calcium channel transport protein for screening and identifying modulator of ion transport; for prevention and treatment of nervous tissue injuries and diabetes
11/20/2003US20030215888 Genetically engineered myoblast for identifying antiproliferative agents; antiapoptosis; drug screening
11/20/2003US20030215880 Motif-grafted hybrid polypeptides and uses thereof
11/20/2003US20030215879 Comprise enzymatic polypeptide for use in the treatment of inflammation; aniinflammatory agents
11/20/2003US20030215874 Isolated GRP94 ligand binding domain polypeptide and nucleic acid encoding same, crystalline form of same, and screening methods employing same
11/20/2003US20030215860 G-protein coupled receptors for diagnosis, prevention and treatment of nervous system, cell proliferative, pain, metabolic, hormonal kidney and brain disorders
11/20/2003US20030215859 Biocatalytic polypeptides having improved stereospecificity for production of hydroxycarboxylic acids and aryl/alkyl-hydroxy compounds; glycosyltransferases; improved solvent resistance of microorganisms used; drug screening
11/20/2003US20030215852 Novel pancortin-Pablo protein interactions and methods of use thereof
11/20/2003US20030215840 Identifying compounds capable of treating atherosclerosis, reperfusion injury, hypertension, restenosis, arterial inflammation, heart failure, thrombosis and endothelial cell disorders
11/20/2003US20030215836 Bone morphogenic protein polynucleotides, polypeptides, and antibodies
11/20/2003US20030215831 Renal regulatory elements and methods of use thereof
11/20/2003US20030215829 Nuclear hormone receptors
11/20/2003US20030215823 Uses of galanin GALR2 receptors
11/20/2003US20030215822 Comprises nucleotide sequences coding polypeptide for use in diagnosis, treatment and prevention of cell proliferative, autoimmune/inflammatory, cardiovascular, neurological and developmental disorder
11/20/2003US20030215819 Compositions and methods for inferring a response to statin
11/20/2003US20030215803 Isolated polynucleotide which hybridizes to given sequence; use in diagnosing cancer and for inhibiting tumor growth
11/20/2003US20030215796 Detecting and differentiating viruses or intracellular parasites present in a specimen; inoculating culture with pathogen and observing for its presence
11/20/2003US20030215792 Nucleic acid molecule comprising a nucleic acid sequence coding for a chemokine, a neuropeptide precursor, or at least on neuropeptide
11/20/2003US20030215782 Frozen spermatozoa compositions and uses thereof
11/20/2003US20030215466 Which is incapable of reproduction within human cell lines; for treatment of human immunodeficency virus
11/20/2003US20030215461 Immunogenic composition comprising adenyl cyclase-hemolysin protein, or portion thereof, strain of Bordetella chosen from B.pertussis, B.parapertussis or B.bronchiseptica, bacterial extract containing expression product of bordetella vrg genes
11/20/2003US20030215457 Comprising a nucleic acid, a polypeptide encoded by the nucleic acid, and a compound, preferably an antibody or fragment thereof, that binds to the polypeptide, preferably binding to the extracellular domain of LIV-1 polypeptide
11/20/2003US20030215452 Methods and compositions for treating hematological disorders using 131, 148, 199, 12303, 13906, 15513, 17822, 302, 5677, 194, 14393, 28059, 7366, 12212, 1981, 261, 12416, 270, 1410, 137, 1871, 13051, 1847, 1849, 15402, 340, 10217, 837, 1761, 8990 or 13249 molecules
11/20/2003US20030215450 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders
11/20/2003US20030215447 Produced by hybridoma cell line DSM ACC 2533
11/20/2003US20030215444 And stimulate erythropoiesis; teatment of anemia
11/20/2003US20030215434 Treatment of multiple sclerosis (MS)
11/20/2003US20030215428 Methods for stimulating nervous system regeneration and repair by regulating arginase I and polyamine synthesis
11/20/2003US20030215427 CE7-specific redirected immune cells
11/20/2003US20030215426 Redifferentiated cells for repairing cartilage defects
11/20/2003US20030215425 Epitope synchronization in antigen presenting cells
11/20/2003US20030215402 Porphyromonas gingivalis recombinant proteins and truncations
11/20/2003CA2523888A1 Transgenic rat and the use thereof in the animal model for human huntingdon's disease and nuclear constructs, vectors and cells for the production thereof
1 ... 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 ... 1827